Literature DB >> 24790915

A case of isolated lymphoblastic relapse of the central nervous system in a patient with chronic myelogenous leukemia treated with imatinib.

Mi-Jung Park1, Pil-Whan Park1, Yiel-Hea Seo1, Kyung-Hee Kim1, Ja-Young Seo1, Ji-Hun Jeong1, Moon Jin Kim1, Jin-Woo Jeong1, Jeong-Yeal Ahn1, Jinny Park2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24790915      PMCID： PMC3999326          DOI： 10.3343/alm.2014.34.3.247

Source DB:  PubMed          Journal:  Ann Lab Med        ISSN： 2234-3806            Impact factor:   3.464


× No keyword cloud information.
  19 in total

1.  Isolated central nervous system relapse in patients with chronic myeloid leukemia on imatinib mesylate.

Authors:  Nathalie A Johnson; Raouf Fetni; Stephen N Caplan
Journal:  Leuk Lymphoma       Date:  2005-04

2.  Isolated blast crisis in CNS in a patient with chronic myelogenous leukemia maintaining major cytogenetic response after imatinib.

Authors:  Hyun Jung Kim; Chul Won Jung; Kihyun Kim; Jin Seok Ahn; Won Seog Kim; Kwan Park; Young Hye Ko; Won Ki Kang; Keunchil Park
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

3.  Isolated central nervous system lymphoid blast crisis in chronic myeloid leukaemia in major molecular remission.

Authors:  A Barlow; M Robertson; A Doig; W Stewart; M W Drummond
Journal:  Br J Haematol       Date:  2008-05-15       Impact factor: 6.998

4.  CNS blast crisis of chronic myelogenous leukemia in a patient with a major cytogenetic response in bone marrow associated with low levels of imatinib mesylate and its N-desmethylated metabolite in cerebral spinal fluid.

Authors:  Martin Bornhauser; Andreas Jenke; Jens Freiberg-Richter; Jörgen Radke; Ulrich S Schuler; Brigitte Mohr; Gerhard Ehninger; Eberhard Schleyer
Journal:  Ann Hematol       Date:  2003-12-12       Impact factor: 3.673

5.  Prognostic discrimination in "good-risk" chronic granulocytic leukemia.

Authors:  J E Sokal; E B Cox; M Baccarani; S Tura; G A Gomez; J E Robertson; C Y Tso; T J Braun; B D Clarkson; F Cervantes
Journal:  Blood       Date:  1984-04       Impact factor: 22.113

6.  Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy.

Authors:  K J Aichberger; S Herndlhofer; H Agis; W R Sperr; H Esterbauer; W Rabitsch; P Knöbl; O A Haas; R Thalhammer; I Schwarzinger; C Sillaber; U Jäger; P Valent
Journal:  Eur J Clin Invest       Date:  2007-08-28       Impact factor: 4.686

Review 7.  Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate.

Authors:  Y Isobe; K Sugimoto; A Masuda; Y Hamano; K Oshimi
Journal:  Intern Med J       Date:  2009-06       Impact factor: 2.048

Review 8.  Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.

Authors:  Michele Baccarani; Jorge Cortes; Fabrizio Pane; Dietger Niederwieser; Giuseppe Saglio; Jane Apperley; Francisco Cervantes; Michael Deininger; Alois Gratwohl; François Guilhot; Andreas Hochhaus; Mary Horowitz; Timothy Hughes; Hagop Kantarjian; Richard Larson; Jerald Radich; Bengt Simonsson; Richard T Silver; John Goldman; Rudiger Hehlmann
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

9.  Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

Authors:  Mary Fuchs; Mike Reinhöfer; Andreas Ragoschke-Schumm; Herbert G Sayer; Klas Böer; Otto W Witte; Andreas Hochhaus; Hubertus Axer
Journal:  BMC Blood Disord       Date:  2012-08-07

10.  Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report.

Authors:  Abdullah Altintas; Timucin Cil; Ilhan Kilinc; Muhammet Ali Kaplan; Orhan Ayyildiz
Journal:  J Neurooncol       Date:  2007-02-23       Impact factor: 4.506
View more
  4 in total

Review 1.  Isolated CNS Blast Crises in Chronic Myeloid Leukaemia Presenting as Hypertrophic Pachymeningitis and Bilateral Optic Neuritis: A Case Report.

Authors:  Ankur Jain; Naresh Gupta
Journal:  J Clin Diagn Res       Date:  2016-01-01

Review 2.  Chronic myelogenous leukemia presenting with central nervous system infiltration, successfully treated with central nervous system-directed chemotherapy followed by allogeneic stem cell transplantation.

Authors:  Akira Chiba; Takashi Toya; Hideaki Mizuno; Junji Tokushige; Fumihiko Nakamura; Kumi Nakazaki; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2018-08-04       Impact factor: 2.490

3.  Isolated central nervous system relapse in chronic myeloid leukemia.

Authors:  Juliana Gomez; Victor Duenas
Journal:  Case Rep Med       Date:  2015-03-23

4.  Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib.

Authors:  M K Angelopoulou; J V Asimakopoulos; Z Galani; G Levidou; M Roumelioti; T P Vassilakopoulos; P Korkolopoulou; P Panayiotidis
Journal:  Blood Cancer J       Date:  2016-08-26       Impact factor: 11.037
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.